Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
1993 1
1994 1
1996 1
1998 1
2000 1
2003 1
2006 1
2007 1
2008 3
2010 1
2013 4
2015 3
2016 1
2021 1
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Results by year

Filters applied: . Clear all
Page 1
The pharmacotherapy of hypochondriasis.
Fallon BA, Schneier FR, Marshall R, Campeas R, Vermes D, Goetz D, Liebowitz MR. Fallon BA, et al. Among authors: vermes d. Psychopharmacol Bull. 1996;32(4):607-11. Psychopharmacol Bull. 1996. PMID: 8993081 Review.
Maximizing remission from cognitive-behavioral therapy in medicated adults with obsessive-compulsive disorder.
Simpson HB, Foa EB, Wheaton MG, Gallagher T, Gershkovich M, Schmidt AB, Huppert JD, Campeas RB, Imms PA, Cahill SP, DiChiara C, Tsao SD, Puliafico AC, Chazin D, Asnaani A, Moore K, Tyler J, Steinman SA, Sanchez-LaCay A, Capaldi S, Snorrason I, Turk-Karan E, Vermes D, Kalanthroff E, Pinto A, Hahn CG, Xu B, Van Meter PE, Katechis M, Scodes J, Wang Y. Simpson HB, et al. Among authors: vermes d. Behav Res Ther. 2021 Aug;143:103890. doi: 10.1016/j.brat.2021.103890. Epub 2021 May 29. Behav Res Ther. 2021. PMID: 34089924 Free PMC article.
Maintenance of Wellness in Patients With Obsessive-Compulsive Disorder Who Discontinue Medication After Exposure/Response Prevention Augmentation: A Randomized Clinical Trial.
Foa EB, Simpson HB, Gallagher T, Wheaton MG, Gershkovich M, Schmidt AB, Huppert JD, Imms P, Campeas RB, Cahill S, DiChiara C, Tsao SD, Puliafico A, Chazin D, Asnaani A, Moore K, Tyler J, Steinman SA, Sanches-LaCay A, Capaldi S, Snorrason Í, Turk-Karan E, Vermes D, Kalanthroff E, Pinto A, Hamlett GE, Middleton R, Hahn CG, Xu B, Van Meter PE, Katechis M, Rosenfield D. Foa EB, et al. Among authors: vermes d. JAMA Psychiatry. 2022 Mar 1;79(3):193-200. doi: 10.1001/jamapsychiatry.2021.3997. JAMA Psychiatry. 2022. PMID: 35080598 Free PMC article. Clinical Trial.
Low dose selegiline (L-Deprenyl) in social phobia.
Simpson HB, Schneier FR, Marshall RD, Campeas RB, Vermes D, Silvestre J, Davies S, Liebowitz MR. Simpson HB, et al. Among authors: vermes d. Depress Anxiety. 1998;7(3):126-9. Depress Anxiety. 1998. PMID: 9656093 Clinical Trial. No abstract available.
Childhood trauma and dissociative symptoms in panic disorder.
Marshall RD, Schneier FR, Lin SH, Simpson HB, Vermes D, Liebowitz M. Marshall RD, et al. Among authors: vermes d. Am J Psychiatry. 2000 Mar;157(3):451-3. doi: 10.1176/appi.ajp.157.3.451. Am J Psychiatry. 2000. PMID: 10698824
COMBINED MIRTAZAPINE AND SSRI TREATMENT OF PTSD: A PLACEBO-CONTROLLED TRIAL.
Schneier FR, Campeas R, Carcamo J, Glass A, Lewis-Fernandez R, Neria Y, Sanchez-Lacay A, Vermes D, Wall MM. Schneier FR, et al. Among authors: vermes d. Depress Anxiety. 2015 Aug;32(8):570-9. doi: 10.1002/da.22384. Epub 2015 Jun 26. Depress Anxiety. 2015. PMID: 26115513 Free PMC article. Clinical Trial.
A double-masked, placebo-controlled study of fluoxetine for hypochondriasis.
Fallon BA, Petkova E, Skritskaya N, Sanchez-Lacay A, Schneier F, Vermes D, Cheng J, Liebowitz MR. Fallon BA, et al. Among authors: vermes d. J Clin Psychopharmacol. 2008 Dec;28(6):638-45. doi: 10.1097/JCP.0b013e31818d21cf. J Clin Psychopharmacol. 2008. PMID: 19011432 Clinical Trial.
23 results